Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTi-Inoc: Exhaled nitric oxide to monitor compliance with inhaled steroids in asthma (pilot)
2005-002009-22Phase 4Completed
- Sponsor
- Valeas
- Start
- Jan 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of flunisolide in asthma, sponsored by Valeas. Primary endpoint: Relationship between exhaled nitric oxide and compliance with inhaled flunisolide. Started Jan 2007; status: completed.
02
Drugs
flunisolide
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-002009-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002009-22.